history of the company
“ViraNovinTebZagros” Co. , as a manufacturer of diagnostic products, is a renowned member of the profession in this field. The continuous growth of the company is dedicated to the work of experienced and mainly professional company led by committed managers who are engaged in various sectors of production, sales, commerce, services and technical support, scientific-educational, research and development. The company, while benefiting from continuous experience, has been able to diversify the products and services provided in its life cycle, through the quantitative and qualitative development of activities and focusing on continuous improvement of operations, as well as addressing customer satisfaction, in addition to the physical development of the company, in At present, the main share of the activities is to provide knowledge and services in the field of laboratory products and to allocate a special place among its colleagues in such a way that the controls and examinations of competent experts of the quality as well as the adequacy of the services And performance records, confirming the ability and familiarity of the managers and specialists of the company with the latest and advanced The most commonly used knowledge and information is the ISO 13485 functional and international standards. Currently, the company has been active in producing diagnostic and confirmatory kits for psychotropic drugs and psychotropic substances using the Randomized Immunoassay (TLC) and Thin Chromatography (TLC) assays, and subsequently managed to produce LE-TLC, a method It is different and fast in confirming the positive samples of the screening stage. Also, for all its products, it has received quality approvals and manufacturing licenses from the Ministry of Health.
Tests for the detection of addiction are one of the main pillars of the country’s drug addiction control program. Experiments on addictive and unauthorized drugs are performed in two steps. The first step involves a screening test (immuno-chromatography) that is performed to detect and distinguish negative samples from probable positive samples. The second stage of confirmatory testing (TLC thin-layer chromatography) is to identify the drug or its metabolites, which is likely to occur At the screening stage it is specified.
Standards and color reagents